National Pension Service Grows Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

National Pension Service increased its stake in shares of IQVIA Holdings Inc. (NYSE:IQV) by 12.7% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 435,067 shares of the medical research company’s stock after acquiring an additional 49,130 shares during the period. National Pension Service’s holdings in IQVIA were worth $103,098,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Park Place Capital Corp purchased a new stake in IQVIA in the 3rd quarter valued at approximately $28,000. Versant Capital Management Inc boosted its holdings in IQVIA by 733.3% in the 2nd quarter. Versant Capital Management Inc now owns 125 shares of the medical research company’s stock valued at $26,000 after purchasing an additional 110 shares in the last quarter. Opal Wealth Advisors LLC purchased a new stake in IQVIA in the 2nd quarter valued at approximately $27,000. Itau Unibanco Holding S.A. purchased a new stake in IQVIA in the 2nd quarter valued at approximately $29,000. Finally, International Assets Investment Management LLC purchased a new stake in IQVIA in the 2nd quarter valued at approximately $32,000. Hedge funds and other institutional investors own 89.62% of the company’s stock.

Insider Activity

In other news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the transaction, the insider now owns 19,536 shares of the company’s stock, valued at approximately $4,812,302.88. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Evercore ISI reduced their price target on shares of IQVIA from $270.00 to $265.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $270.00 target price on shares of IQVIA in a research note on Friday. Argus raised IQVIA to a “strong-buy” rating in a research note on Wednesday, July 31st. Redburn Atlantic started coverage on IQVIA in a research note on Monday, October 14th. They set a “buy” rating and a $276.00 price target on the stock. Finally, The Goldman Sachs Group reduced their price target on IQVIA from $280.00 to $250.00 and set a “buy” rating on the stock in a research note on Friday. Four analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, IQVIA presently has a consensus rating of “Moderate Buy” and a consensus target price of $261.56.

IQVIA Stock Up 0.5 %

Shares of IQVIA stock opened at $210.19 on Tuesday. The business has a 50-day moving average of $233.55 and a 200-day moving average of $229.64. The company has a debt-to-equity ratio of 1.76, a current ratio of 0.81 and a quick ratio of 0.81. The company has a market capitalization of $38.15 billion, a PE ratio of 27.58, a P/E/G ratio of 2.07 and a beta of 1.51. IQVIA Holdings Inc. has a 1-year low of $190.20 and a 1-year high of $261.73.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.